671. Why Has There Been So Little Progress on Alzheimer’s Disease?
A major investigative report reveals widespread data manipulation and research misconduct in Alzheimer's research, centered on the dominant amyloid hypothesis, raising serious questions about decades of scientific direction, regulatory oversight, and the future of treatment.
THESIS —
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Guest
Charles Piller
solo on Freakonomics Radio
Mentions
Books, people, and resources mentioned in this episode.
People
Books
Companies
Research & Papers
Topics
Listen to This Episode
More from Freakonomics Radio
664. Are Thousands of Medical Cures Hiding in Plain Sight?
667. Here’s Why You Are Constantly Fighting Off Scammers
All You Need Is Nudge (Update)
668. Do Taylor Swift and Bad Bunny Have Blood on Their Hands?
666. This Is How Progress Happens
The Curious Mr. Feynman (Update)
Related episodes
From other shows on similar topics.
10,000 Steps a Day Could Cut Alzheimer’s Risk in Half | Robert Love | DSH #1853
Digital Social Hour
#300 Louisa Nicola - Peptides, Cancer and the Deadly Habits That Lead to Alzheimer’s
The Shawn Ryan Show
Cognitive Decline Expert: The Disease That Starts in Your 30s but Kills You in Your 70s
The Diary Of A CEO with Steven Bartlett
Is It Possible to Hack Your Body for a Longer Life?
On with Kara Swisher
Can We Reverse Aging?
The Daily
#374 - "Doctors Are Legally BANNED From Telling You This" - Pharma Whistleblower | Brigham Buhler
Danny Jones Podcast
Get summaries like this every morning.
Free AI-powered recaps of Freakonomics Radio and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.